• (+5411) 3965-8409
  • Esta dirección de correo electrónico está siendo protegida contra los robots de spam. Necesita tener JavaScript habilitado para poder verlo.


Kundro MA, Viloria GA, Toibaro JJ, Losso MH. Antiretroviral therapy and arterial elasticity in HIV-infected patients. Medicina (B Aires). 2017;77(5):365-369. PubMed PMID: 29044011.

Stankievich E, Malanca A, Foradori I, Ivalo S, Losso M. Utility of Mobile Communication Devices as a Tool to Improve Adherence to Antiretroviral Treatment in HIV-Infected Children and Young Adults in Argentina. Pediatr Infect Dis J. 2017 Oct 7.

Cozzi-Lepri A, Zangerle R, Machala L, Zilmer K, Ristola M, Pradier C, Kirk O, Sambatakou H, Fätkenheuer G, Yust I, Schmid P, Gottfredsson M, Khromova I, Jilich D, Flisiak R, Smidt J, Rozentale B, Radoi R, Losso MH, Lundgren JD, Mocroft A; EuroSIDA Study Group. Incidence of cancer and overall risk of mortality in individuals treated with raltegravir-based and non-raltegravir-based combination antiretroviral therapy regimens. HIV Med. 2017 Oct 6.

Beigel JH, Bao Y, Beeler J, Manosuthi W, Slandzicki A, Dar SM, Panuto J, Beasley RL, Perez-Patrigeon S, Suwanpimolkul G, Losso MH, McClure N, Bozzolo DR, Myers C, Holley HP Jr, Hoopes J, Lane HC, Hughes MD, Davey RT; IRC003 Study Team. Oseltamivir, amantadine, and ribavirin combination antiviral therapy versus oseltamivir monotherapy for the treatment of influenza: a multicentre, double-blind, randomised phase 2 trial. Lancet Infect Dis. 2017 Dec;17(12):1255-1265.

Pett SL, Amin J, Horban A, Andrade-Villanueva J, Losso M, Porteiro N, Madero JS, Belloso W, Tu E, Silk D, Kelleher A, Harrigan R, Clark A, Sugiura W, Wolff M, Gill J, Gatell J, Clarke A, Ruxrungtham K, Prazuck T, Kaiser R, Woolley I, Alberto Arnaiz J, Cooper D, Rockstroh JK, Mallon P, Emery S; MARCH study group. Week 96 results of the randomized, multicentre Maraviroc Switch (MARCH) study. HIV Med. 2018 Jan;19(1):65-71. Epub 2017 Jul 13.

Currier JS, Britto P, Hoffman RM, Brummel S, Masheto G, Joao E, Santos B, Aurpibul L, Losso M, Pierre MF, Weinberg A, Gnanashanmugam D, Chakhtoura N, Klingman K, Browning R, Coletti A, Mofenson L, Shapiro D, Pilotto J; 1077HS PROMISE Team. Randomized trial of stopping or continuing ART among postpartum women with pre-ART CD4 ≥ 400 cells/mm3. PLoS One. 2017 May

Malanca A, Foradori I, Stankievich E, Pandullo H, Losso M. [Disclosure of human immunodeficiency virus diagnosis in children and adolescents affected by it and their caregivers]. Arch Argent Pediatr. 2017 Apr 1;115(2):195-199.

TB:HIV Study writing Group. One-year mortality of HIV-positive patients treated for rifampicin- and isoniazid-susceptible tuberculosis in Eastern Europe, Western Europe, and Latin America. AIDS. 2017 Jan 28;31(3):375-384.

Pett SL, Kunisaki KM, Wenworth D, y col. Increased indoleamine 2-3 Dioxygenase activity is associated with poor clinical outcome in adults hospitalized with influenza in the INSIGHT FLU003Plus study. Open Forum Infect Dis 2017; Oct 25, 5(1)

Dwyer DE, Lynfield R, Losso MH, y col. Comparison of the outcomes of individuals with medically attended influenza A and B virus infections enrolled in 2 international cohort studies over a 6 year period: 2009-2015. Open Forum Infect Dis 2017; Oct 7;4(4)

Vazquez C, Orlova M, Angriman F, Minatta JN, Scibona P, Verzura MA, Jáuregui EG, Díaz de Arce H, Pallotta MG, Belloso WH. Prediction of severe toxicity in adult patients under treatment with 5-fluoruracil: a prospective cohort study. Anticancer Drugs 2017; Oct 28(9):1039-46.

Pett SL, Amin J, Horban A, Andrade-Villanueva J, Losso M, Porteiro N, Madero JS, Belloso WH, Tu E, Silk D, Kelleher A, y col. Week 96 results of the randomized multicentre Maraviroc Switch (MARCH) study. HIV Med 2017; Jul 13

Achhra AC, Mocroft A, Ross M, Ryom-Nyelson L, Avihingsanon A, Bakowska E, Belloso WH, Clarke A, Furrer H, Lucas GM, Ristola M, Rassool M, Ross J, y col. Impact of early versus deferred antiretroviral therapy on estimated glomerular filtration rate in HIV-positive individuals in the START Trial. Int J Antimicrob Agents 2017; Jun 28

Vazquez C, Orlova M, Scibona P, Diaz Arce H, Pallotta MG, Belloso WH. Prevalence of thymidylate synthase gene 5´untranslated region variants in an Argentinean sample. Gen Mol res 2017; 16(1)

Boyd MA, Amin J, Mallon PW, Kumarasamy N, Lombaard J, Wood R, Chetchotisakd P, Phanuphak P, Mohapi L, Azwa I, Belloso WH, Molina JM, Hoy J, Moore CL, Emery S, Cooper DA; SECOND-LINE Study Group. Body composition and metabolic outcomes after 96 weeks of treatment with ritonavir-boosted lopinavir plus either nucleoside or nucleotide reverse transcriptase inhibitors or raltegravir in patients with HIV with virological failure of a standard first-line antiretroviral therapy regimen: a substudy of the randomised, open-label, non-inferiority SECOND-LINE study. Lancet HIV. 2017 Jan;4(1):e13-e20.


Urquiza 358, Balvanera (CP 1215).
Ciudad Autónoma de Buenos Aires, Argentina

Tel.: (+5411) 3965-8409

Es un proyecto sin fines de lucro de


© 2024 CICAL. Todos los derechos reservados.